Management of primary vesico-ureteric reflux in children — Operation ineffective in preventing progressive renal damage J. Winberg Session I Pages: S4 - S7
Proposals regarding guidelines for the evaluation of new antibacterial drugs for the treatment of UTI in children T. MatsumotoS. KuboK. Senoh Session I Pages: S8 - S9
Aspects of clinical trials of drug efficacy in children with uncomplicated infections U. Jodal Session I Pages: S10 - S11
What evidence is there for the use of single-dose therapy for urinary tract infections in children? R. R. Bailey Session I Pages: S14 - S15
Clinical evaluation of drug efficacy in UTI in men: The significance of bacterial elimination on day one S. ArakawaS. Kamidono Session II Pages: S23 - S26
Unsolved mysteries of UTIs in men. Commentary on A. J. Schaeffer's paper B. A. Lipsky Session II Pages: S27 - S29
Urinary tract infection in men — An internist's viewpoint J. W. SmithM. Segal Session II Pages: S31 - S32
Guidelines for urinary tract infections. Rationale for a separate strata for patients with “low-count” bacteriuria C. M. Kunin Round Table Discussion Pages: S38 - S40
Urine sampling method and significance of bacteriuria in men K. G. Naber Round Table Discussion Pages: S44 - S46
Single-dose/short-term therapy in children and in pregnant women R. R. Bailey Round Table Discussion Pages: S47 - S48
Duration of antimicrobial treatment and the use of drug combinations for the treatment of uncomplicated acute pyelonephritis R. R. Bailey Round Table Discussion Pages: S50 - S52
Control and duration of therapy in complicated UTI — With special consideration of C-reactive protein D. Höffler Round Table Discussion Pages: S53 - S54
Comparison of complicated urinary tract infections in men and women Y. Kawada Round Table Discussion Pages: S55 - S57
Proposed study design in prostatitis K. G. NaberHelen Giamarellou Round Table Discussion Pages: S59 - S60
3rd international symposium on clinical evaluation of drug efficacy in urinary tract infection 1993 Announcement Pages: S69 - S69
